Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Meningococcal Vaccine Market 2018, Forecast to 2023

Publisher Name :
Date: 11-Jun-2018
No. of pages: 134

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

Scope of the Report:

This report focuses on the Meningococcal Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Top-down and bottom-up approaches are used to validate the global Meningococcal Vaccinesize market and estimate the market size for manufacturers, regions segments, product segments and applications.

The market estimations in this report are based on the marketed sale price of Meningococcal Vaccine. The percentage splits, Market Share, and breakdowns of the product segments are derived on the basis of weightages assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Meningococcal Vaccine market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major players in the market are identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top manufacturers; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, Market Share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYR Pharma & Healthcare Research Center and presented in this report.

The worldwide market for Meningococcal Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Novartis

- GSK

- Merck

- CSL

- Baxter

- JN International Medical Corporation

- Serum Institute of India

- Bio-Med

- China National Biotec Group

- Hualan Bio

- Walvax

- Zhifei

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Quadrivalent

- Bivalent

- Others

Market Segment by Applications, can be divided into

- Pneumonia

- Meningitis

- Bacteremia

- Others (Arthritis, Conjunctivitis, Urethritis)

There are 15 Chapters to deeply display the global Meningococcal Vaccine market.

Chapter 1, to describe Meningococcal Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Meningococcal Vaccine, with sales, revenue, and price of Meningococcal Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Meningococcal Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Meningococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Meningococcal Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Meningococcal Vaccine Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Meningococcal Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Quadrivalent
1.2.2 Bivalent
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Pneumonia
1.3.2 Meningitis
1.3.3 Bacteremia
1.3.4 Others (Arthritis, Conjunctivitis, Urethritis)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.1.1 Novartis Description
2.1.1.2 Novartis Headquarter, Main Business and Finance Overview
2.1.2 Novartis Meningococcal Vaccine Product Introduction
2.1.2.1 Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.1.2.2 Meningococcal Vaccine Product Information
2.1.3 Novartis Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Novartis Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Novartis Meningococcal Vaccine Market Share in 2017
2.2 GSK
2.2.1 Business Overview
2.2.1.1 GSK Description
2.2.1.2 GSK Headquarter, Main Business and Finance Overview
2.2.2 GSK Meningococcal Vaccine Product Introduction
2.2.2.1 Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.2.2.2 Meningococcal Vaccine Product Information
2.2.3 GSK Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 GSK Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global GSK Meningococcal Vaccine Market Share in 2017
2.3 Merck
2.3.1 Business Overview
2.3.1.1 Merck Description
2.3.1.2 Merck Headquarter, Main Business and Finance Overview
2.3.2 Merck Meningococcal Vaccine Product Introduction
2.3.2.1 Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.3.2.2 Meningococcal Vaccine Product Information
2.3.3 Merck Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Merck Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Merck Meningococcal Vaccine Market Share in 2017
2.4 CSL
2.4.1 Business Overview
2.4.1.1 CSL Description
2.4.1.2 CSL Headquarter, Main Business and Finance Overview
2.4.2 CSL Meningococcal Vaccine Product Introduction
2.4.2.1 Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.4.2.2 Meningococcal Vaccine Product Information
2.4.3 CSL Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 CSL Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global CSL Meningococcal Vaccine Market Share in 2017
2.5 Baxter
2.5.1 Business Overview
2.5.1.1 Baxter Description
2.5.1.2 Baxter Headquarter, Main Business and Finance Overview
2.5.2 Baxter Meningococcal Vaccine Product Introduction
2.5.2.1 Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.5.2.2 Meningococcal Vaccine Product Information
2.5.3 Baxter Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Baxter Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Baxter Meningococcal Vaccine Market Share in 2017
2.6 JN International Medical Corporation
2.6.1 Business Overview
2.6.1.1 JN International Medical Corporation Description
2.6.1.2 JN International Medical Corporation Headquarter, Main Business and Finance Overview
2.6.2 JN International Medical Corporation Meningococcal Vaccine Product Introduction
2.6.2.1 Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.6.2.2 Meningococcal Vaccine Product Information
2.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global JN International Medical Corporation Meningococcal Vaccine Market Share in 2017
2.7 Serum Institute of India
2.7.1 Business Overview
2.7.1.1 Serum Institute of India Description
2.7.1.2 Serum Institute of India Headquarter, Main Business and Finance Overview
2.7.2 Serum Institute of India Meningococcal Vaccine Product Introduction
2.7.2.1 Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.7.2.2 Meningococcal Vaccine Product Information
2.7.3 Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Serum Institute of India Meningococcal Vaccine Market Share in 2017
2.8 Bio-Med
2.8.1 Business Overview
2.8.1.1 Bio-Med Description
2.8.1.2 Bio-Med Headquarter, Main Business and Finance Overview
2.8.2 Bio-Med Meningococcal Vaccine Product Introduction
2.8.2.1 Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.8.2.2 Meningococcal Vaccine Product Information
2.8.3 Bio-Med Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Bio-Med Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Bio-Med Meningococcal Vaccine Market Share in 2017
2.9 China National Biotec Group
2.9.1 Business Overview
2.9.1.1 China National Biotec Group Description
2.9.1.2 China National Biotec Group Headquarter, Main Business and Finance Overview
2.9.2 China National Biotec Group Meningococcal Vaccine Product Introduction
2.9.2.1 Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.9.2.2 Meningococcal Vaccine Product Information
2.9.3 China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global China National Biotec Group Meningococcal Vaccine Market Share in 2017
2.10 Hualan Bio
2.10.1 Business Overview
2.10.1.1 Hualan Bio Description
2.10.1.2 Hualan Bio Headquarter, Main Business and Finance Overview
2.10.2 Hualan Bio Meningococcal Vaccine Product Introduction
2.10.2.1 Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.10.2.2 Meningococcal Vaccine Product Information
2.10.3 Hualan Bio Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Hualan Bio Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Hualan Bio Meningococcal Vaccine Market Share in 2017
2.11 Walvax
2.11.1 Business Overview
2.11.2 Walvax Meningococcal Vaccine Product Introduction
2.11.3 Walvax Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Zhifei
2.12.1 Business Overview
2.12.2 Zhifei Meningococcal Vaccine Product Introduction
2.12.3 Zhifei Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Meningococcal Vaccine Market Competition, by Manufacturer
3.1 Global Meningococcal Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Meningococcal Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Meningococcal Vaccine Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Meningococcal Vaccine Manufacturer Market Share in 2017
3.4.2 Top 5 Meningococcal Vaccine Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Meningococcal Vaccine Market Analysis by Regions
4.1 Global Meningococcal Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Meningococcal Vaccine Sales by Regions (2013-2018)
4.1.2 Global Meningococcal Vaccine Revenue by Regions (2013-2018)
4.2 North America Meningococcal Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Meningococcal Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Meningococcal Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Meningococcal Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Meningococcal Vaccine Sales, Revenue and Growth Rate (2013-2018)
5 North America Meningococcal Vaccine by Countries, Type, Application and Manufacturers
5.1 North America Meningococcal Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Meningococcal Vaccine Sales by Countries (2013-2018)
5.1.2 North America Meningococcal Vaccine Revenue by Countries (2013-2018)
5.1.3 United States Meningococcal Vaccine Sales and Growth Rate (2013-2018)
5.1.4 Canada Meningococcal Vaccine Sales and Growth Rate (2013-2018)
5.1.5 Mexico Meningococcal Vaccine Sales and Growth Rate (2013-2018)
5.2 North America Meningococcal Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Meningococcal Vaccine Sales by Manufacturers (2016-2017)
5.2.2 North America Meningococcal Vaccine Revenue by Manufacturers (2016-2017)
5.3 North America Meningococcal Vaccine Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Meningococcal Vaccine Sales and Sales Share by Type (2013-2018)
5.3.2 North America Meningococcal Vaccine Revenue and Revenue Share by Type (2013-2018)
5.4 North America Meningococcal Vaccine Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Meningococcal Vaccine Sales and Sales Share by Application (2013-2018)
5.4.2 North America Meningococcal Vaccine Revenue and Revenue Share by Application (2013-2018)
6 Europe Meningococcal Vaccine by Countries, Type, Application and Manufacturers
6.1 Europe Meningococcal Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Meningococcal Vaccine Sales by Countries (2013-2018)
6.1.2 Europe Meningococcal Vaccine Revenue by Countries (2013-2018)
6.1.3 Germany Meningococcal Vaccine Sales and Growth Rate (2013-2018)
6.1.4 UK Meningococcal Vaccine Sales and Growth Rate (2013-2018)
6.1.5 France Meningococcal Vaccine Sales and Growth Rate (2013-2018)
6.1.6 Russia Meningococcal Vaccine Sales and Growth Rate (2013-2018)
6.1.7 Italy Meningococcal Vaccine Sales and Growth Rate (2013-2018)
6.2 Europe Meningococcal Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Meningococcal Vaccine Sales by Manufacturers (2016-2017)
6.2.2 Europe Meningococcal Vaccine Revenue by Manufacturers (2016-2017)
6.3 Europe Meningococcal Vaccine Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Meningococcal Vaccine Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Meningococcal Vaccine Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Meningococcal Vaccine Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Meningococcal Vaccine Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Meningococcal Vaccine Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Meningococcal Vaccine by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Meningococcal Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Meningococcal Vaccine Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Meningococcal Vaccine Revenue by Countries (2013-2018)
7.1.3 China Meningococcal Vaccine Sales and Growth Rate (2013-2018)
7.1.4 Japan Meningococcal Vaccine Sales and Growth Rate (2013-2018)
7.1.5 Korea Meningococcal Vaccine Sales and Growth Rate (2013-2018)
7.1.6 India Meningococcal Vaccine Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Meningococcal Vaccine Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Meningococcal Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Meningococcal Vaccine Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Meningococcal Vaccine Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Meningococcal Vaccine Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Meningococcal Vaccine Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Meningococcal Vaccine Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Meningococcal Vaccine Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Meningococcal Vaccine Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Meningococcal Vaccine Revenue and Revenue Share by Application (2013-2018)
8 South America Meningococcal Vaccine by Countries, Type, Application and Manufacturers
8.1 South America Meningococcal Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Meningococcal Vaccine Sales by Countries (2013-2018)
8.1.2 South America Meningococcal Vaccine Revenue by Countries (2013-2018)
8.1.3 Brazil Meningococcal Vaccine Sales and Growth Rate (2013-2018)
8.1.4 Argentina Meningococcal Vaccine Sales and Growth Rate (2013-2018)
8.1.5 Colombia Meningococcal Vaccine Sales and Growth Rate (2013-2018)
8.2 South America Meningococcal Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Meningococcal Vaccine Sales by Manufacturers (2016-2017)
8.2.2 South America Meningococcal Vaccine Revenue by Manufacturers (2016-2017)
8.3 South America Meningococcal Vaccine Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Meningococcal Vaccine Sales and Sales Share by Type (2013-2018)
8.3.2 South America Meningococcal Vaccine Revenue and Revenue Share by Type (2013-2018)
8.4 South America Meningococcal Vaccine Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Meningococcal Vaccine Sales and Sales Share by Application (2013-2018)
8.4.2 South America Meningococcal Vaccine Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Meningococcal Vaccine by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Meningococcal Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Meningococcal Vaccine Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Meningococcal Vaccine Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Meningococcal Vaccine Sales and Growth Rate (2013-2018)
9.1.4 UAE Meningococcal Vaccine Sales and Growth Rate (2013-2018)
9.1.5 Egypt Meningococcal Vaccine Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Meningococcal Vaccine Sales and Growth Rate (2013-2018)
9.1.7 South Africa Meningococcal Vaccine Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Meningococcal Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Meningococcal Vaccine Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Meningococcal Vaccine Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Meningococcal Vaccine Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Meningococcal Vaccine Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Meningococcal Vaccine Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Meningococcal Vaccine Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Meningococcal Vaccine Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Meningococcal Vaccine Revenue and Revenue Share by Application (2013-2018)
10 Global Meningococcal Vaccine Market Segment by Type
10.1 Global Meningococcal Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Meningococcal Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Meningococcal Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Quadrivalent Sales Growth and Price
10.2.1 Global Quadrivalent Sales Growth (2013-2018)
10.2.2 Global Quadrivalent Price (2013-2018)
10.3 Bivalent Sales Growth and Price
10.3.1 Global Bivalent Sales Growth (2013-2018)
10.3.2 Global Bivalent Price (2013-2018)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2013-2018)
10.4.2 Global Others Price (2013-2018)
11 Global Meningococcal Vaccine Market Segment by Application
11.1 Global Meningococcal Vaccine Sales Market Share by Application (2013-2018)
11.2 Pneumonia Sales Growth (2013-2018)
11.3 Meningitis Sales Growth (2013-2018)
11.4 Bacteremia Sales Growth (2013-2018)
11.5 Others (Arthritis, Conjunctivitis, Urethritis) Sales Growth (2013-2018)
12 Meningococcal Vaccine Market Forecast (2018-2023)
12.1 Global Meningococcal Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Meningococcal Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Meningococcal Vaccine Market Forecast (2018-2023)
12.2.2 Europe Meningococcal Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Meningococcal Vaccine Market Forecast (2018-2023)
12.2.4 South America Meningococcal Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Meningococcal Vaccine Market Forecast (2018-2023)
12.3 Meningococcal Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Meningococcal Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Meningococcal Vaccine Market Share Forecast by Type (2018-2023)
12.4 Meningococcal Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Meningococcal Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Meningococcal Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Meningococcal Vaccine Picture
Table Product Specifications of Meningococcal Vaccine
Figure Global Meningococcal Vaccine CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Meningococcal Vaccine CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Meningococcal Vaccine by Types in 2017
Figure Quadrivalent Picture
Table Major Manufacturers of Quadrivalent
Figure Bivalent Picture
Table Major Manufacturers of Bivalent
Figure Others Picture
Table Major Manufacturers of Others
Figure Meningococcal Vaccine Sales Market Share by Applications in 2017
Figure Pneumonia Picture
Figure Meningitis Picture
Figure Bacteremia Picture
Figure Others (Arthritis, Conjunctivitis, Urethritis) Picture
Figure United States Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure France Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure UK Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure China Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure India Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Meningococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table Novartis Meningococcal Vaccine Product
Table Novartis Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Meningococcal Vaccine Sales Market Share in 2017
Figure Global Novartis Meningococcal Vaccine Revenue Market Share in 2017
Table GSK Headquarter, Established, Main Business and Finance Overview (2017)
Table GSK Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table GSK Meningococcal Vaccine Product
Table GSK Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GSK Meningococcal Vaccine Sales Market Share in 2017
Figure Global GSK Meningococcal Vaccine Revenue Market Share in 2017
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table Merck Meningococcal Vaccine Product
Table Merck Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Meningococcal Vaccine Sales Market Share in 2017
Figure Global Merck Meningococcal Vaccine Revenue Market Share in 2017
Table CSL Headquarter, Established, Main Business and Finance Overview (2017)
Table CSL Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table CSL Meningococcal Vaccine Product
Table CSL Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CSL Meningococcal Vaccine Sales Market Share in 2017
Figure Global CSL Meningococcal Vaccine Revenue Market Share in 2017
Table Baxter Headquarter, Established, Main Business and Finance Overview (2017)
Table Baxter Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table Baxter Meningococcal Vaccine Product
Table Baxter Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Baxter Meningococcal Vaccine Sales Market Share in 2017
Figure Global Baxter Meningococcal Vaccine Revenue Market Share in 2017
Table JN International Medical Corporation Headquarter, Established, Main Business and Finance Overview (2017)
Table JN International Medical Corporation Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table JN International Medical Corporation Meningococcal Vaccine Product
Table JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global JN International Medical Corporation Meningococcal Vaccine Sales Market Share in 2017
Figure Global JN International Medical Corporation Meningococcal Vaccine Revenue Market Share in 2017
Table Serum Institute of India Headquarter, Established, Main Business and Finance Overview (2017)
Table Serum Institute of India Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table Serum Institute of India Meningococcal Vaccine Product
Table Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Serum Institute of India Meningococcal Vaccine Sales Market Share in 2017
Figure Global Serum Institute of India Meningococcal Vaccine Revenue Market Share in 2017
Table Bio-Med Headquarter, Established, Main Business and Finance Overview (2017)
Table Bio-Med Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table Bio-Med Meningococcal Vaccine Product
Table Bio-Med Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bio-Med Meningococcal Vaccine Sales Market Share in 2017
Figure Global Bio-Med Meningococcal Vaccine Revenue Market Share in 2017
Table China National Biotec Group Headquarter, Established, Main Business and Finance Overview (2017)
Table China National Biotec Group Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table China National Biotec Group Meningococcal Vaccine Product
Table China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global China National Biotec Group Meningococcal Vaccine Sales Market Share in 2017
Figure Global China National Biotec Group Meningococcal Vaccine Revenue Market Share in 2017
Table Hualan Bio Headquarter, Established, Main Business and Finance Overview (2017)
Table Hualan Bio Meningococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table Hualan Bio Meningococcal Vaccine Product
Table Hualan Bio Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Hualan Bio Meningococcal Vaccine Sales Market Share in 2017
Figure Global Hualan Bio Meningococcal Vaccine Revenue Market Share in 2017
Table Walvax
Table Walvax Meningococcal Vaccine
Table Zhifei
Table Zhifei Meningococcal Vaccine
Table Global Meningococcal Vaccine Sales by Manufacturer (2016-2017)
Figure Global Meningococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure Global Meningococcal Vaccine Sales Market Share by Manufacturer in 2017
Table Global Meningococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure Global Meningococcal Vaccine Revenue Market Share by Manufacturer in 2016
Figure Global Meningococcal Vaccine Revenue Market Share by Manufacturer in 2017
Table Global Meningococcal Vaccine Price by Manufacturer (2016-2017)
Figure Top 3 Meningococcal Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Meningococcal Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Global Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Global Meningococcal Vaccine Revenue and Growth Rate (2013-2018)
Table Global Meningococcal Vaccine Sales by Regions (2013-2018)
Table Global Meningococcal Vaccine Sales Market Share by Regions (2013-2018)
Table Global Meningococcal Vaccine Revenue by Regions (2013-2018)
Figure Global Meningococcal Vaccine Revenue Market Share by Regions in 2013
Figure Global Meningococcal Vaccine Revenue Market Share by Regions in 2017
Figure North America Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Figure North America Meningococcal Vaccine Revenue and Growth Rate (2013-2018)
Figure Europe Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Meningococcal Vaccine Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Meningococcal Vaccine Revenue and Growth Rate (2013-2018)
Figure South America Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Figure South America Meningococcal Vaccine Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Meningococcal Vaccine Revenue and Growth Rate (2013-2018)
Figure North America Meningococcal Vaccine Revenue and Growth Rate (2013-2018)
Table North America Meningococcal Vaccine Sales by Countries (2013-2018)
Table North America Meningococcal Vaccine Sales Market Share by Countries (2013-2018)
Figure North America Meningococcal Vaccine Sales Market Share by Countries in 2013
Figure North America Meningococcal Vaccine Sales Market Share by Countries in 2017
Table North America Meningococcal Vaccine Revenue by Countries (2013-2018)
Table North America Meningococcal Vaccine Revenue Market Share by Countries (2013-2018)
Figure North America Meningococcal Vaccine Revenue Market Share by Countries in 2013
Figure North America Meningococcal Vaccine Revenue Market Share by Countries in 2017
Figure United States Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Canada Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Mexico Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Table North America Meningococcal Vaccine Sales by Manufacturer (2016-2017)
Figure North America Meningococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure North America Meningococcal Vaccine Sales Market Share by Manufacturer in 2017
Table North America Meningococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure North America Meningococcal Vaccine Revenue Market Share by Manufacturer in 2016
Figure North America Meningococcal Vaccine Revenue Market Share by Manufacturer in 2017
Table North America Meningococcal Vaccine Sales by Type (2013-2018)
Table North America Meningococcal Vaccine Sales Share by Type (2013-2018)
Table North America Meningococcal Vaccine Revenue by Type (2013-2018)
Table North America Meningococcal Vaccine Revenue Share by Type (2013-2018)
Table North America Meningococcal Vaccine Sales by Application (2013-2018)
Table North America Meningococcal Vaccine Sales Share by Application (2013-2018)
Table North America Meningococcal Vaccine Revenue by Application (2013-2018)
Table North America Meningococcal Vaccine Revenue Share by Application (2013-2018)
Figure Europe Meningococcal Vaccine Revenue and Growth Rate (2013-2018)
Table Europe Meningococcal Vaccine Sales by Countries (2013-2018)
Table Europe Meningococcal Vaccine Sales Market Share by Countries (2013-2018)
Table Europe Meningococcal Vaccine Revenue by Countries (2013-2018)
Figure Europe Meningococcal Vaccine Revenue Market Share by Countries in 2016
Figure Europe Meningococcal Vaccine Revenue Market Share by Countries in 2017
Figure Germany Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Figure UK Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Figure France Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Russia Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Italy Meningococcal Vaccine Sales and Growth Rate (2013-2018)
Table Europe Meningococcal Vaccine Sales by Manufacturer (2016-2017)
Figure Europe Meningococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure Europe Meningococcal Vaccine Sales Market Share by Manufacturer in 2017
Table Europe Meningococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure Europe Meningococcal Vaccine Revenue Market Share by Manufacturer in 2016
Figure Europe Meningococcal Vaccine Revenue Market Share by Manufacturer in 2017
Table Europe Meningococcal Vaccine Sales by Type (2013-2018)
Table Europe Meningococcal Vaccine Sales Share by Type (2013-2018)
Table Europe Meningococcal Vaccine Revenue by Type (2013-2018)
Table Europe Meningococcal Vaccine Revenue Share by Type (2013-2018)
Table Europe Meningococcal Vaccine Sales by Application (2013-2018)
Table Europe Meningococcal Vaccine Sales Share by Application (2013-2018)
Table Europe Meningococcal Vaccine Revenue by Application (2013-2018)
Table Europe Meningococcal Vaccine Revenue Share by Application (2013-2018)
Figure Asia-Pacific Meningococcal Vaccine Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Meningococcal Vaccine Sales by Countries (2013-2018)
Table Asia-Pacific Meningococcal Vaccine Sales Market Share by Countries (2013-2018)
Figure Asi
  • Global Lactulose Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Jun-2018        Price: US 3480 Onwards        Pages: 132
    Lactulose a "bifidus factor" is composed of galactose and fructose, which can be produced by the isomerization of lactose. It is a prebiotic carbohydrate which stimulates the growth of health-promoting bacteria in the gastrointestinal tract, it can also be used for the treatment of constipation, hepatic encephalopathy, tumour prevention, and to maintain blood glucose and insulin level. Scope of the Report: This report focuses on the Lactulose in global market, especially i......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Lactulose Market 2018, Forecast to 2023
    Published: 21-Jun-2018        Price: US 4880 Onwards        Pages: 136
    Lactulose a "bifidus factor" is composed of galactose and fructose, which can be produced by the isomerization of lactose. It is a prebiotic carbohydrate which stimulates the growth of health-promoting bacteria in the gastrointestinal tract, it can also be used for the treatment of constipation, hepatic encephalopathy, tumour prevention, and to maintain blood glucose and insulin level. Scope of the Report: This report focuses on the Lactulose in global market, especially i......
  • Global Legal Marijuana Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Jun-2018        Price: US 3480 Onwards        Pages: 132
    Marijuana is one of the most abused drugs in the world. The commercial marijuana industry exists on a state-by-state basis, and all medical and recreational programs are technically in violation of federal drug laws. The U.S. Department of Justice issued some guidelines in recent years that helped the marijuana industry gain traction, but these are not legally binding and could theoretically be nullified at any time. A medicinal cannabis product refers to a product which includes can......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Legal Marijuana Market 2018, Forecast to 2023
    Published: 20-Jun-2018        Price: US 4880 Onwards        Pages: 132
    Marijuana is one of the most abused drugs in the world. The commercial marijuana industry exists on a state-by-state basis, and all medical and recreational programs are technically in violation of federal drug laws. The U.S. Department of Justice issued some guidelines in recent years that helped the marijuana industry gain traction, but these are not legally binding and could theoretically be nullified at any time. A medicinal cannabis product refers to a product which includes can......
  • Global Deferiprone Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Jun-2018        Price: US 3480 Onwards        Pages: 112
    Nerve damages can be caused by either blunt trauma, such as an impact from a fall or from traction injuries from motor vehicle accidents, or sharp trauma, such as direct cuts from a knife. Injury to a nerve can stop signals to and from the brain. Surgical nerve repair involves the exploration of the injured nerve and the removal of injured tissue from the nerve endings. Nerve repair and regeneration product are used through surgical interventions to restore normal function in nerves. ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Deferiprone Market 2018, Forecast to 2023
    Published: 20-Jun-2018        Price: US 4880 Onwards        Pages: 115
    Nerve damages can be caused by either blunt trauma, such as an impact from a fall or from traction injuries from motor vehicle accidents, or sharp trauma, such as direct cuts from a knife. Injury to a nerve can stop signals to and from the brain. Surgical nerve repair involves the exploration of the injured nerve and the removal of injured tissue from the nerve endings. Nerve repair and regeneration product are used through surgical interventions to restore normal function in nerves. ......
  • Global Deferasirox Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Jun-2018        Price: US 3480 Onwards        Pages: 111
    Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias. Scope of the Report: This report focuses on the Deferasirox in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Deferasirox Market 2018, Forecast to 2023
    Published: 20-Jun-2018        Price: US 4880 Onwards        Pages: 117
    Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias. Scope of the Report: This report focuses on the Deferasirox in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • Global Minocycline Hydrochloride Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Jun-2018        Price: US 3480 Onwards        Pages: 111
    Minocycline Hydrochloride, also called minocycline HCL, is a broad-spectrum tetracycline antibiotic, and has a broader spectrum than the other members of the group. It is a bacteriostatic antibiotic, classified as a long-acting type. As a result of its long half-life it generally has serum levels 2-4 times that of the simple water-soluble tetracyclines. The CAS Number is 13614-98-7. Scope of the Report: This report focuses on the Minocycline Hydrochloride in global ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs